NOVONIX (ASX: NVX) lapses 5.78M performance rights and updates capital
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
NOVONIX Limited reported a change to its share capital after certain employee-style awards lapsed. On 30 June 2026, a total of 5,781,507 NVXAD PERFORMANCE RIGHTS ceased due to the lapse of conditional rights where vesting conditions were not, or could not be, satisfied. The company confirmed it paid no consideration for this cessation.
After this change, NOVONIX’s issued capital includes 991,561,920 NVX ordinary fully paid shares on issue and unquoted equity securities such as 21,619,875 NVXAD performance rights, 14,016,667 NVXAA options, 1,371,566 NVXAB share rights and 45,221,586 NVXAL convertible notes.
Positive
- None.
Negative
- None.
Key Figures
Performance rights lapsed: 5,781,507 NVXAD performance rights
Ordinary shares on issue: 991,561,920 NVX ordinary fully paid
Remaining performance rights: 21,619,875 NVXAD performance rights
+4 more
7 metrics
Performance rights lapsed
5,781,507 NVXAD performance rights
Ceased on 30/06/2026 due to unmet conditions
Ordinary shares on issue
991,561,920 NVX ordinary fully paid
Quoted equity securities after cessation
Remaining performance rights
21,619,875 NVXAD performance rights
Unquoted equity securities on issue
Options on issue
14,016,667 NVXAA options
Unquoted, expiring various dates at various prices
Share rights on issue
1,371,566 NVXAB share rights
Unquoted equity securities
Convertible notes on issue
45,221,586 NVXAL convertible notes
Unquoted equity-linked securities
Cessation consideration
No consideration paid
For lapse of 5,781,507 performance rights
Key Terms
PERFORMANCE RIGHTS, lapse of conditional right to securities, issued capital, convertible notes, +1 more
5 terms
PERFORMANCE RIGHTS financial
"NVXAD PERFORMANCE RIGHTS 5,781,507 Lapse of conditional right to securities"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
lapse of conditional right to securities financial
"Lapse of conditional right to securities because the conditions have not been, or have become incapable"
issued capital financial
"We (the entity named above) provide the following information about our issued capital."
convertible notes financial
"NVXAL CONVERTIBLE NOTES 45,221,586"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
unquoted equity securities financial
"Unquoted +equity securities that have ceased Number of securities that have ceased"
FAQ
What change to NOVONIX (NVX) securities was announced in June 2026?
NOVONIX reported the cessation of 5,781,507 NVXAD PERFORMANCE RIGHTS on 30 June 2026. These rights lapsed because their conditions were not met or became incapable of being satisfied, reducing the pool of outstanding performance rights.
Why did 5,781,507 NOVONIX NVXAD performance rights lapse?
The 5,781,507 NVXAD PERFORMANCE RIGHTS lapsed due to a "lapse of conditional right to securities". The filing states the conditions attached to these rights were not met, or became incapable of being satisfied, so the rights ceased under their original terms.
Did NOVONIX pay any consideration for the cessation of these performance rights?
No, NOVONIX stated it is not paying any consideration for the cessation of the 5,781,507 NVXAD performance rights. This means the rights simply lapsed under their conditions, without any cash or other compensation being paid by the company.
How many NOVONIX performance rights remain on issue after the lapse?
After the lapse of 5,781,507 NVXAD performance rights, NOVONIX reported 21,619,875 NVXAD PERFORMANCE RIGHTS on issue. These remaining rights are unquoted equity securities and are separate from the company’s quoted ordinary fully paid shares on the ASX.
What other unquoted NOVONIX securities are currently on issue?
NOVONIX lists several unquoted securities: 21,619,875 NVXAD performance rights, 14,016,667 NVXAA options, 1,371,566 NVXAB share rights and 45,221,586 NVXAL convertible notes. These instruments sit alongside the company’s 991,561,920 quoted ordinary shares on the ASX.
